Publication
Prognostic value of reduced heart rate reserve during exercise in hypertrophic cardiomyopathy
dc.contributor.author | Ciampi, Quirino | |
dc.contributor.author | Olivotto, Iacopo | |
dc.contributor.author | Peteiro, Jesus | |
dc.contributor.author | D’Alfonso, Maria | |
dc.contributor.author | Mori, Fabio | |
dc.contributor.author | Tassetti, Luigi | |
dc.contributor.author | Milazzo, Alessandra | |
dc.contributor.author | Monserrat, Lorenzo | |
dc.contributor.author | Fernandez, Xusto | |
dc.contributor.author | Pálinkás, Attila | |
dc.contributor.author | Pálinkás, Eszter | |
dc.contributor.author | Sepp, Róbert | |
dc.contributor.author | Re, Federica | |
dc.contributor.author | Cortigiani, Lauro | |
dc.contributor.author | Tesic, Milorad | |
dc.contributor.author | Djordjevic-Dikic, Ana | |
dc.contributor.author | Beleslin, Branko | |
dc.contributor.author | Losi, Mariangela | |
dc.contributor.author | Canciello, Grazia | |
dc.contributor.author | Betocchi, Sandro | |
dc.contributor.author | Lopes, Luis | |
dc.contributor.author | Cruz, Ines | |
dc.contributor.author | Cotrim, Carlos | |
dc.contributor.author | Torres, Marco | |
dc.contributor.author | Bellagamba, Clarissa | |
dc.contributor.author | Van De Heyning, Caroline | |
dc.contributor.author | Varga, Albert | |
dc.contributor.author | Ágoston, Gergely | |
dc.contributor.author | Villari, Bruno | |
dc.contributor.author | Lorenzoni, Valentina | |
dc.contributor.author | Carpeggiani, Clara | |
dc.contributor.author | Picano, Eugenio | |
dc.date.accessioned | 2021-04-27T17:43:05Z | |
dc.date.available | 2021-04-27T17:43:05Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Background: Sympathetic dysfunction can be evaluated by heart rate reserve (HRR) with exercise test. Objectives: To determine the value of HRR in predicting outcome of patients with hypertrophic cardiomyopathy (HCM). Methods: We enrolled 917 HCM patients (age = 49 +/- 15 years, 516 men) assessed with exercise stress echocardiography (ESE) in 11 centres. ESE modality was semi-supine bicycle in 51 patients (6%), upright bicycle in 476 (52%), and treadmill in 390 (42%). During ESE, we assessed left ventricular outflow tract obstruction (LVOTO), stress-induced new regional wall motion abnormalities (RWMA), and HRR (peak/rest heart rate, HR). By selection, all patients completed the follow-up. Mortality was the predetermined outcome measure Results: During ESE, RWMA occurred in 22 patients (2.4%) and LVOTO (>= 50 mmHg) in 281 (30.4%). HRR was 1.90 +/- 0.40 (lowest quartile <= 1.61, highest quartile > 2.13). Higher resting heart rate (odds ratio 1.027, 95% CI: 1.018-1.036, p < 0.001), older age (odds ratio 1.021, 95% CI: 1.009-1.033, p < 0.001), lower exercise tolerance (mets, odds ratio 0.761, 95% CI: 0.708-0.817, p < 0.001) and resting LVOTO (odds ratio 1.504, 95% CI: 1.043-2.170, p = 0.029) predicted a reduced HRR. During a median follow-up of 89 months (interquartile range: 36-145 months), 90 all-cause deaths occurred. At multivariable analysis, lowest quartile HRR (Hazard ratio 2.354, 95% CI 1.116-4.968 p = 0.025) and RWMA (Hazard ratio 3.279, 95% CI 1.441-7.461 p = 0.004) independently predicted death, in addition to age (Hazard ratio 1.064, 95% CI 1.043-1.085 p < 0.001) and maximal wall thickness (Hazard ratio 1.081, 95% CI 1.037-1.128, p < 0.001). Conclusions: A blunted HRR during ESE predicts survival independently of RWMA in HCM patients. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.doi | 10.3390/jcm10071347 | pt_PT |
dc.identifier.issn | 2077-0383 | |
dc.identifier.uri | http://hdl.handle.net/10400.1/15454 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | MDPI | pt_PT |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
dc.subject | Autonomic dysfunction | pt_PT |
dc.subject | Stress echocardiography | pt_PT |
dc.subject | Hypertrophic cardiomyopathy | pt_PT |
dc.title | Prognostic value of reduced heart rate reserve during exercise in hypertrophic cardiomyopathy | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.issue | 7 | pt_PT |
oaire.citation.startPage | 1347 | pt_PT |
oaire.citation.title | Journal of Clinical Medicine | pt_PT |
oaire.citation.volume | 10 | pt_PT |
person.familyName | Cotrim | |
person.givenName | Carlos | |
person.identifier.ciencia-id | 1B11-CED8-69A1 | |
person.identifier.orcid | 0000-0002-4802-0831 | |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
relation.isAuthorOfPublication | def25fde-92b5-4f4f-a790-f1ae043f8519 | |
relation.isAuthorOfPublication.latestForDiscovery | def25fde-92b5-4f4f-a790-f1ae043f8519 |
Files
Original bundle
1 - 1 of 1